Hemodialysis using heparin-bound hemophan in patients at risk of bleeding

Nephron - Clinical Practice

Volumn 97, Issue 1, 2004, Pages

  Lee, Kyu Beck ^a   Kim, Beom ^a   Lee, Yoon Ha ^a   Yoon, Soo Jin ^a   Kang, Woo Hun ^a   Huh, Wooseong ^a   Kim, Dae Joong ^a   Oh, Ha Young ^a   Kim, Yoon Goo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Anticoagulation; Hemodialysis; Hemophan; Heparin

Indexed keywords

HEPARIN; SODIUM CHLORIDE; UREA;

ADULT; AGED; ARTICLE; ARTIFICIAL KIDNEY; BLEEDING; BLOOD CLOTTING; BLOOD VOLUME; CONTROLLED STUDY; DRUG BINDING; DRUG BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT OUTCOME;

ADSORPTION; ADULT; AGED; ANTICOAGULANTS; BIOCOMPATIBLE MATERIALS; CELLULOSE; CROSS-OVER STUDIES; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDIES; RENAL DIALYSIS;

EID: 2642565165     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077589     Document Type: Article

References (19)

1. Gordon LA, Simon ER, Rukes JM, Richards V, Perkins HA: Studies in regional heparinization. N Engl J Med 1956;255:1063-1066.
2. Maher JF, Lapierre L, Schreiner GE, Geiger M, Westervelt JB: Regional heparinization for hemodialysis. N Engl J Med 1963;268:451-456.
3. Swartz RD, Port FK: Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin. Kidney Int 1979;16:513-518.
4. Sanders PW, Taylor H, Curtis JJ: Hemodialysis without anticoagulation. Am J Kidney Dis 1985;5:32-35.
5. Schwab SJ, Onorato JJ, Sharar LR, Dennis PA: Hemodialysis without anticoagulation: One-year prospective trial in hospitalized patients at risk for bleeding. Am J Med 1987;83:405-410.
6. Pinnick RV, Wiegmann TB, Diederich DA: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983;308:258-261.
7. Swartz RD, Flamenbaum W, Dubrow A, et al: Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complications. J Clin Pharmacol 1988;28:818-825.
8. Lohr JW, Schwab SJ: Minimizing hemorrhagic complications in dialysis patients. J Am Soc Nephrol 1991;2:961-975.
9. Holland FF GH, Mason RG, Klein E: Thrombogenicity of heparin-bound DEAE cellulose hemodialysis membranes. ASAIO J 1978;1:24-36.
10. Gretz N, Schulz S, Bowry S, et al: Heparin adsorption to different dialyser membranes by means of a modified rinsing procedure. Presented at 31st Congress of the European dialysis and Transplant Association, July 3-6. Abstracts ERA-EDTA 1994;9:184.
11. Mujais SK, Chimeh H: Heparin-free hemodialysis using heparin-coated hemophan. ASAIO J 1996;42:M538-541.
12. Vienken J, Gretz N, Bowry S: Interaction of heparin with positively charged dialysis membranes allows heparin-free dialysis. ASAIO Abstr 1994;23:78.
13. Chai J, Diao L, Sheng Z, et al: Heparin-free hemodialysis in the treatment of hypernatremia in severely burned patients. Burns 2000;26:634-637.
14. Gotch FA SJ: A mechanistic analysis of the national cooperative dialysis study (NCDS). Kidney Int 1985;28:526-534.
15. Wei SS, Ellis PW, Magnusson MO, Paganini EP: Effect of heparin modeling on delivered hemodialysis therapy. Am J Kidney Dis 1994;23:389-393.
16. Agresti J, Conroy JD, Olshan A, et al: Heparinfree hemodialysis with Cuprophan hollow fiber dialyzers by a frequent saline flush, high blood flow technique. Trans Am Soc Artif Intern Organs 1985;31:590-594.
17. Caruana RJ, Raja RM, Bush JV, Kramer MS, Goldstein SJ: Heparin free dialysis: comparative data and results in high risk patients. Kidney Int 1987;31:1351-1355.
18. Casati S, Moia M, Graziani G, et al: Hemodialysis without anticoagulants: efficiency and hemostatic aspects. Clin Nephrol 1984;21:102-105.
19. Renaux JL, Atti M: The AN69ST dialysis membrane. Contrib Nephrol. Basel, Karger, 2002, vol 137, pp 111-119.